March 6, 2026

Disclaimer: The information provided here is for educational purposes only and is not intended as medical advice. It should not be used to diagnose, treat, cure, or prevent any medical condition. Instead, use it as a starting point for discussion with your healthcare provider. Always consult with a qualified healthcare provider before starting any new medication, supplement, device, or making changes to your health regimen.
For individuals living with complex chronic conditions like Long COVID, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and dysautonomia, sleep is rarely just about feeling rested. It is a nightly battle against a nervous system that refuses to power down, a brain that feels inflamed, and a body that wakes up more exhausted than when it went to bed. You might find yourself staring at the ceiling at 3 AM, heart racing, trapped in a frustrating cycle of being entirely "wired but tired." Standard sleep aids often leave you feeling groggy, hungover, or completely fail to keep you asleep through the night. This is a common and deeply validating experience for those navigating post-viral illnesses, where the fundamental architecture of sleep has been disrupted at a cellular level.
Enter melatonin, a hormone naturally produced by the body that does far more than just induce sleep. In the context of chronic illness, melatonin acts as a potent antioxidant, a neuroprotective agent, and a regulator of the autonomic nervous system. However, because the body clears standard melatonin rapidly, many patients wake up after only a few hours. Melatonin SRT™ by Designs for Health offers a 6 mg sustained-release formulation designed to mimic the body's natural physiological secretion pattern. By slowly releasing melatonin throughout the night, it provides prolonged support for those who struggle with sleep maintenance, frequent awakenings, and the deep, restorative rest required for cellular healing.
Sustained-release melatonin supports restorative sleep and helps reduce early morning awakenings in complex chronic illnesses.
It acts as a potent antioxidant, helping protect mitochondria and manage neuroinflammation in Long COVID.
Melatonin may help calm the nervous system, supporting dysautonomia patients with "wired but tired" symptoms.
Always consult your doctor before starting melatonin, especially if taking SSRIs or beta-blockers.
Melatonin (N-acetyl-5-methoxytryptamine) is a highly conserved hormone synthesized primarily by the pineal gland, a small endocrine gland located deep within the brain. Often referred to by chronobiologists as the "chemical expression of darkness," melatonin serves as the body’s primary chronobiotic regulator. Its fundamental role is to translate environmental light and dark cycles into biological signals that every cell in the body can understand. In a healthy system, melatonin levels begin to rise in the evening as daylight fades, peak in the middle of the night, and gradually fall to baseline levels by morning, signaling the body that it is time to wake up.
Beyond its role as a sleep initiator, melatonin is a profound systemic regulator. It is an endogenous antioxidant, meaning it is produced natively within the body to neutralize harmful free radicals and protect cellular structures from oxidative damage. Furthermore, melatonin interacts closely with the immune system and the autonomic nervous system, helping to lower core body temperature, reduce blood pressure, and calm the "fight or flight" sympathetic response to prepare the body for restorative rest.
The production of melatonin is a fascinating, multi-step biochemical process that relies heavily on the availability of specific precursors and cofactors. The pathway begins with L-tryptophan, an essential amino acid acquired through the diet. Tryptophan is first hydroxylated by the enzyme tryptophan hydroxylase to form 5-hydroxytryptophan (5-HTP). This intermediate is then decarboxylated to become serotonin, a crucial neurotransmitter associated with mood and gastrointestinal motility.
The transformation of serotonin into melatonin is where the magic of the circadian rhythm occurs. The rate-limiting step of this pathway is controlled by an enzyme called arylalkylamine N-acetyltransferase (AANAT). AANAT activity is highly sensitive to light; it rhythmically peaks in the dark and is rapidly degraded when the eyes are exposed to light. AANAT converts serotonin into N-acetylserotonin. Finally, a second enzyme, ASMT, adds a methyl group to create the final melatonin molecule. Because this pathway is so delicate, any disruption in tryptophan availability, serotonin production, or light exposure can severely impair the body's ability to generate adequate melatonin.
The timing of melatonin synthesis is governed by the suprachiasmatic nucleus (SCN) of the hypothalamus, which acts as the mammalian "master clock." The SCN receives direct input from intrinsically photosensitive retinal ganglion cells in the eyes via the retinohypothalamic tract. During the day, the bright light detected by these cells prompts the SCN to inhibit the sympathetic nervous system's signals to the pineal gland, effectively halting melatonin production.
When darkness falls, this inhibition is lifted. The SCN triggers the release of norepinephrine, which binds to beta-adrenergic receptors on the pineal gland. This binding activates a cascade of intracellular signaling, ultimately turning on the AANAT enzyme and causing a massive spike in melatonin synthesis. Once released into the cerebrospinal fluid and bloodstream, melatonin feeds back into the SCN, binding to specific receptors to phase-shift and resynchronize the master clock's electrical activity, ensuring that the entire body operates on a cohesive 24-hour schedule.
One of the primary challenges with endogenous melatonin is its incredibly short half-life. Once secreted, melatonin is rapidly metabolized by the liver and cleared from the bloodstream in roughly 40 to 60 minutes. For healthy individuals, the pineal gland continuously pumps out melatonin throughout the night to maintain sleep. However, when supplementing with standard, immediate-release melatonin, the body receives a sudden, massive spike of the hormone that clears within a few hours, often leading to early morning awakenings.
Melatonin SRT™ utilizes a sustained-release (SR) matrix to overcome this pharmacokinetic hurdle. By slowly dissolving over several hours, the tablet closely mimics the brain's natural pineal gland secretion pattern. This gradual release ensures that therapeutic plasma levels of melatonin are maintained throughout the critical 4-to-8-hour sleep window. For patients who have no trouble falling asleep but find themselves wide awake at 3 AM, this sustained delivery is essential for bridging the gap and promoting uninterrupted, restorative sleep architecture.